clinical experience with palliationof metastatic adenocarcinoma with5-fluorouracil chemotherapychemotherapy of solid tumors is becoming amore and more helpful therapeutic tool.  itis probable that within a few years chemother-apy will become firmly established as an ad-junct to the primary treatment of solid tumors.perhaps someday a cancerocidal chemical willbe devised that can actually act as antibioticsdo on bacteria.  for this reason it is importantfor all surgeons interested in the treatment ofcancer to try to keep abreast of the recent ad-vances in the field of chemotherapy.  surgeonsshould also begin to use some of the technics forpalliation of incurable patients so that whenthese drugs are added to the armamentarium ofprimary treatment of cancer, they will befamiliar with the various technics and the modeof actions of the drugs.5-fluorouracil (5-fu) has had extensive clin-ical use and has produced significant palliationin breast and colon cancers with about a thirdof these patients receiving palliation for five tosix months.